GeneTether Therapeutics Inc (CSE: GTTX)
Biotechnology
Increasing the correction efficiency of targeted gene editing technologies
About us
GeneTether Therapeutics (CSE: GTTX) is focused on developing its disruptive proprietary platform technology to significantly increase the efficiency of DNA insertion into the genome for gene correction and complementation strategies. GeneTether’s wholly-owned platform technology uses a proprietary method to “tether” donor DNA templates to the genome editing complex, making the template readily available for use during the genome editing repair stage.
- Website
-
https://genetether.com
External link for GeneTether Therapeutics Inc (CSE: GTTX)
- Industry
- Biotechnology
- Company size
- 2-10 employees
- Headquarters
- Toronto
- Type
- Public Company
- Founded
- 2018
- Specialties
- Gene editing, Gene Therapy, Cell Therapy, and Biotechnology
Locations
-
Primary
Get directions
Toronto, CA
-
Get directions
San Francisco Bay Area, US